Citation 7678

TSUSHIMA,M: MAOKA,T: KATSUYAMA,M: KOZUKA,M: MATSUNO,T: TOKUDA,H: NISHINO,H: IWASHIMA,A:. (1995). INHIBITORY EFFECT OF NATURAL CAROTENOIDS ON EPSTEIN-BARR VIRUS ACTIVATION ACTIVITY OF A TUMOR PROMOTER IN RAJI CELLS. A SCREENING STUDY FOR ANTI-TUMOR PROMOTERS.. 18(2)

Citation Details

Title	INHIBITORY EFFECT OF NATURAL CAROTENOIDS ON EPSTEIN-BARR VIRUS ACTIVATION ACTIVITY OF A TUMOR PROMOTER IN RAJI CELLS. A SCREENING STUDY FOR ANTI-TUMOR PROMOTERS.
Authors	TSUSHIMA,M: MAOKA,T: KATSUYAMA,M: KOZUKA,M: MATSUNO,T: TOKUDA,H: NISHINO,H: IWASHIMA,A:
Year	1995
Volume	18
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYTOFLUENE	ACTIVE
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCOPENE	ACTIVE
3	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,GAMMA:	WEAK ACTIVITY
4	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA:	WEAK ACTIVITY
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,ALPHA:	ACTIVE
6	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RENIERATENE,ISO:	ACTIVE
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RENIERATENE,CIS-7-ISO:	ACTIVE
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RENEIERATENE,DICIS-7-7'-ISO:	ACTIVE
9	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTEN-2-OL,BETA:	EQUIVOCAL
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOXANTHIN,BETA:	ACTIVE
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOXANTHIN,ISO:	WEAK ACTIVITY
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEAXANTHIN	ACTIVE
13	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEIN	ACTIVE
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTUCAXANTHIN	ACTIVE
15	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEAXANTHIN,ISO:	WEAK ACTIVITY
16	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE-4-4'-DIOL,BETA-BETA: 5-5'-6-6'-TETRAHYDROXY:	ACTIVE
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LOROXANTHIN	WEAK ACTIVITY
18	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE-3-3'-4-4'-TETROL,BETA-BETA:	INACTIVE
19	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ECHINENONE,BETA:	ACTIVE
20	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CANTHAXANTHIN	EQUIVOCAL
21	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTAXANTHIN	ACTIVE
22	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ECHINENONE,3'-HYDROXY:	EQUIVOCAL
23	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHEROIDENONE	EQUIVOCAL
24	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHEROIDENONE,DEMETHYL:	WEAK ACTIVITY
25	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIATOXANTHIN	ACTIVE
26	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLOXANTHIN	WEAK ACTIVITY
27	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTENOLONE	EQUIVOCAL
28	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTENOL A	WEAK ACTIVITY
29	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTENOL B	WEAK ACTIVITY
30	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEOXANTHIN,DEEPOXY:	EQUIVOCAL
31	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEOXANTHIN	ACTIVE
32	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOXANTHINOL	ACTIVE
33	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOXANTHIN	ACTIVE
34	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERIDININ	ACTIVE
35	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOXANTHINOL,ISO:	ACTIVE
36	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HALOCYNTHIAXANTHIN	ACTIVE
37	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMAROUCIAXANTHIN B	ACTIVE
38	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSOSTREAXANTHIN A	ACTIVE
39	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROXANTHIN	ACTIVE
40	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIOLAXANTHIN	WEAK ACTIVITY
41	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CUCURBITAXANTHIN A	ACTIVE
42	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ESCHSCHLOTZXANTHIN	EQUIVOCAL
43	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ESCHSCHOLTZXANTHONE	EQUIVOCAL
44	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHODOXANTHIN	ACTIVE
45	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ESCHOLTZXANTHIN,ANDHYDRO:	WEAK ACTIVITY
46	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPSANTHIN	ACTIVE
47	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYTILOXANTHINONE	EQUIVOCAL
48	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYTILOXANTHIN	EQUIVOCAL
49	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYXOXANTHOPHYLL	WEAK ACTIVITY
50	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSCILLAXANTHIN	EQUIVOCAL
51	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEOXANTHIN-20'-AL-3'-BETA-LACTOSIDE,13'-CIS-7'-8'-DIHYDRO:	WEAK ACTIVITY
52	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-GALLATE,EPI: (-):	ACTIVE
53	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHIZIN	EQUIVOCAL
54	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID	EQUIVOCAL
55	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: (D):	ACTIVE

Citation 7678

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1